Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms, Castration-Resistant

Explore clinical trials studying Prostatic Neoplasms, Castration-Resistant. Study availability and eligibility vary by location and protocol.

59 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms, Castration-Resistant trial results

Active, not recruiting

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

NCT03748641

Conditions
Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Urology Centers Of Alabama Homewood, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 318 locations
View Trial Details
Active, not recruiting

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

NCT03016741

Conditions
Brain Diseases, Castration-Resistant Prostatic Cancer, Central Nervous System Diseases, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Tulane Cancer Center New Orleans, Louisiana, United States
  • University of Minnesota: Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Completed

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

NCT04962919

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • CPO Pucrs Porto Alegre, Rio Grande do Sul, Brazil
  • Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO Santo André, São Paulo, Brazil
  • Sírio Libanês São Paulo, Brazil
  • Centro Paulista de Oncologia São Paulo, Brazil
View all 18 locations
View Trial Details
Completed

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT05848011

Conditions
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, +17 more
Locations
  • United Medical Group Miami, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 61 locations
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT04428788

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Local Institution - 116 Stanford, California, United States
  • Local Institution - 122 Washington D.C., District of Columbia, United States
  • Local Institution - 103 Sarasota, Florida, United States
  • Local Institution - 121 Thomasville, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions